| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 26.740 | 24.158 | 30.533 | 25.406 | 43.132 | 57.871 | 48.787 | 50.871 | 46.809 |
| Total Income - EUR | - | 26.741 | 24.160 | 30.534 | 25.406 | 43.133 | 57.875 | 48.797 | 53.287 | 48.698 |
| Total Expenses - EUR | - | 9.845 | 14.163 | 20.648 | 24.280 | 26.568 | 25.400 | 26.305 | 33.348 | 37.764 |
| Gross Profit/Loss - EUR | - | 16.896 | 9.997 | 9.886 | 1.126 | 16.565 | 32.475 | 22.492 | 19.939 | 10.934 |
| Net Profit/Loss - EUR | - | 16.629 | 9.756 | 9.580 | 872 | 16.237 | 31.998 | 22.004 | 19.416 | 10.457 |
| Employees | - | 4 | 3 | 3 | 2 | 3 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Dr.ercean Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 11.558 | 10.545 | 9.298 | 9.769 | 9.144 | 9.092 | 8.567 | 20.564 |
| Current Assets | - | 17.658 | 12.669 | 14.219 | 6.726 | 22.007 | 35.858 | 30.463 | 25.895 | 8.235 |
| Inventories | - | 0 | 0 | 0 | 293 | 27 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 226 | 4.351 | 310 | 12.196 | 19.070 | 6.756 | 16.574 | 3.499 |
| Cash | - | 17.658 | 12.443 | 9.868 | 6.123 | 9.785 | 16.788 | 23.707 | 9.321 | 4.735 |
| Shareholders Funds | - | 16.673 | 21.867 | 22.451 | 14.458 | 30.421 | 43.551 | 37.300 | 32.344 | 22.114 |
| Social Capital | - | 45 | 11.963 | 11.744 | 11.516 | 11.298 | 11.048 | 11.082 | 11.048 | 10.986 |
| Debts | - | 985 | 2.360 | 2.314 | 1.566 | 1.355 | 1.452 | 2.255 | 2.119 | 6.685 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Dr.ercean Srl